Caribou Biosciences Funding: $40M Raised, Series C (2021)
Caribou Biosciences is a Biotech company based in Berkeley, California. It has raised $40M in total funding. Latest round: Series C.
Caribou Biosciences funding overview
Caribou Biosciences is a Biotech company based in Berkeley, California. Caribou Biosciences has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in March 2021. The round record for Caribou Biosciences runs through 2021; nothing later has been disclosed. Investors on record include Farallon Capital Management, PFM Health Sciences, Ridgeback Capital Investments, AbbVie Ventures, Adage Capital Partners LP, Avego Bioscience Capital and 11 others. 17 distinct backers are named across the disclosed rounds.
Caribou Biosciences at a glance
Total raised
$40M
Latest round
Series C
Latest round date
March 2021
Industry
Biotech
Headquarters
Berkeley, California
Notable investors
Farallon Capital Management, PFM Health Sciences, Ridgeback Capital Investments, AbbVie Ventures, Adage Capital Partners LP, Avego Bioscience Capital, Avidity Partners, Invus
Frequently asked about Caribou Biosciences funding
How much has Caribou Biosciences raised?
Caribou Biosciences has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Caribou Biosciences?
Farallon Capital Management, PFM Health Sciences, Ridgeback Capital Investments, AbbVie Ventures, Adage Capital Partners LP, Avego Bioscience Capital are named among the investors backing Caribou Biosciences.
What was the latest Caribou Biosciences funding round?
The most recent disclosed round is a Series C, announced in March 2021.
Where is Caribou Biosciences based?
Caribou Biosciences is based in Berkeley, California.
What sector does Caribou Biosciences operate in?
Caribou Biosciences is tracked under Biotech from Berkeley, California, with $40M in disclosed funding.
When did Caribou Biosciences last raise?
The last disclosed Caribou Biosciences round closed in March 2021 at Series C.
We update the Caribou Biosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Berkeley and their backers are listed below.
